What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Influx Healthtech Limited IPO?

Influx Healthtech Limited IPO has received a total subscription of 187.32 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Influx Healthtech Limited

ListedSME

Healthcare · NSE

Influx Healthtech Limited, established in September 2020, is a healthcare-focused company that provides contract manufacturing services. It operates as a trusted CDMO (Contract Development and Manufacturing Organization), serving clients across various sectors. The company runs three manufacturing units located in Thane, Maharashtra, with facility sizes of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. Its product range includes tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, effervescent tablets, liquid-fill capsules, candies, gym and sports supplements, as well as skincare, body care, hair care, beard care products, face masks, and soaps. It also manufactures ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. The company supports nutraceutical and cosmetic businesses by handling the entire process from product development to manufacturing and regulatory assistance, allowing clients to concentrate on formulation and market launch. As of June 11, 2025, Influx Healthtech Limited employs 163 full-time staff members.

Price Band

₹91 – ₹96

Issue Size

₹58.57 Cr

Lot Size

1200 shares

GMP

₹20

+20.8%

Est. Listing

₹116

at current GMP

Subscribed

187.32x

overall

Open

18 Jun 2025

20 Jun 2025

Allotment

23 Jun 2025

Refund

24 Jun 2025

Demat Credit

25 Jun 2025

Listing

25 Jun 2025

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

187.32x

Total Demand

QIB Multiplier

137.87x

Institutions & Funds

NII / HNI

481.47x

High Net-Worth

Retail (RII)

117.70x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 187.32x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	1,159,200	159,818,400	137.87x
NIB	870,000	418,878,000	481.47x
RETAIL	2,029,200	238,842,000	117.70x
Total	4,058,400	817,538,400	187.32x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Category	Applications Reserved	Applications Received	Times Subscribed
QIB	—	99	0.00x
NIB	—	21,204	0.00x
RETAIL	—	199,035	0.00x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Influx Healthtech Limited Public Issue & Market Profile

Influx Healthtech Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹58.57 Crores. The shares are offered at a price band of ₹91 to ₹96 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2025-06-20, the basis of allotment is scheduled to be finalized on 2025-06-23. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Maashitla Securities Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Influx Healthtech Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Influx Healthtech Limited IPO is ₹20 per equity share. Based on the upper price band of ₹91 to ₹96 per equity share, the estimated listing price is ₹116 (+20.8% expected listing gain).

What is the expected profit per lot for Influx Healthtech Limited IPO?

With a lot size of 1200 shares and current GMP of ₹20, the expected profit per application lot is approx ₹24,000 (+20.8% gain). Minimum application cost is approx ₹1,15,200.

What is the issue size and price band for Influx Healthtech Limited IPO?

The Influx Healthtech Limited IPO aggregate issue size is ₹58.57 Crores with an equity price band set at ₹91 to ₹96 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,15,200.

How can I check Influx Healthtech Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 187.32x (Retail: 117.70x, QIB: 137.87x, NII: 481.47x). You can track live multiples directly on our dedicated subscription page.

Where and when will Influx Healthtech Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Maashitla Securities Private Limited) and the BSE status verification website on or around 2025-06-23. Investors can verify status using PAN card or application number.

When is the listing date for Influx Healthtech Limited IPO?

Influx Healthtech Limited shares are scheduled to list on NSE on 2025-06-25.